Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrapulmonary pharmacokinetics of inhaled colistin sulfate in critically ill patients
ChiCTR2200055877Phase 4Not yet recruiting
- Sponsor
- Changxing County People's Hospital
- Start
- Jan 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of colistin in hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), Airways Infection and 1 more, sponsored by Changxing County People's Hospital. Primary endpoint: Colistin concentration in miniBALF. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
colistin
03
Conditions
hospital-acquired pneumonia (HAP)ventilator-associated pneumonia (VAP)Airways InfectionRespiratory tract colonization
Beyond the preview
Go deeper on ChiCTR2200055877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055877.